It’s possible their strong cash position got them that deal. If you read one of the articles last night from the US it was posted as a risky buy out for Merck as a one trick pony all eggs in one basket scenario with keytruda
That means dilution which means the price estimate changes from back in the day that were thrown around.
Now obviously comparing it to last weeks buy out is low however maybe this risky keytruda thing has something to do with it. I read nothing similar with Nektar about their deal and yes the bots /manipulation is some BS with a Vwap but what’s done is done
I would be peeved if they said we turned it down and nothing happened and someone else with a combo therapy got taken out instead
I don’t think VLA are stupid enough to make a fool of themselves giving it away for no reason Paul Hopper has a lot of experience in this space and ultimately you have to have a small degree of faith in them or we would still be 60 cents maybe even 55 by today (obviously that contract took weeks to do and the robots knew about it)
Let the kid leave home and finally go to college and maybe get a scholarship if you are lucky
It’s annoying me too having to sell and be in and out and having CGT tax so I’m in no special place compared to anyone Longer term either but it is what it is and getting over $1 would have been an eternity as I said earlier the market was not interested in this as a value invest beyond a deal
VLA Price at posting:
$1.69 Sentiment: Hold Disclosure: Held
